Cargando...
The treatment landscape in thyroid cancer: a focus on cabozantinib
Although patients with thyroid cancer generally fare well, there is a subset for which this is not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer has led to a change in the management of these cases. Since 2011, four multikinase inhibitors (MKIs) have been ap...
Gardado en:
| Publicado en: | Cancer Manag Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4547654/ https://ncbi.nlm.nih.gov/pubmed/26316818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S68373 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|